Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit.

ABSTRACT:

Objective

To describe the prevalence of atrial fibrillation (AF) in patients with rheumatoid arthritis (RA), and to evaluate the proportion of patients with AF receiving guideline-recommended anticoagulation for prevention of stroke, based on data from a large international audit.

Methods

The cohort was derived from the international audit SUrvey of cardiovascular disease Risk Factors in patients with Rheumatoid Arthritis (SURF-RA) which collected data from 17 countries during 2014-2019. We evaluated the prevalence of AF across world regions and explored factors associated with the presence of AF with multivariable logistic regression models. The proportion of AF patients at high risk of stroke (CHA₂DS₂-VASc ≥ 2 in mal

SUBMITTER: Semb AG 

PROVIDER: S-EPMC9479366 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature